There have been few systemic studies of the neuromuscular features of acromegaly.' 2 Muscle weakness in association with well developed musculature has been described,' 2 as has proximal muscle wasting.2 Acromegaly is a well-known cause of entrapment neuropathies, especially median nerve compression in the carpal tunnel.34 A pituitary adenoma by its local effects may cause hormonal deficiencies such as hypothyroidism, which itself may cause "myopathy"' . [5] [6] [7] Hypertrophied fibres have been described in acromegaly.' 8 These studies were performed before the full significance of differences in fibre size from different muscle groups was recognised.9 Thus half the patients had biopsies from the deltoid and half from the quadriceps muscles making interpretation difficult. Recently an innovation has allowed accurate rapid measurements of mean fibre areas using
electronic planimetry'°and subtle changes in type 2 mean fibre area (MFA) in endocrine myopathies have been detected.'' The needle biopsy technique'2 together with strain gauge techniques to measure strength"' and qualitative and quantitative measures of skeletal muscle on computed tomography scanning (CT)'4 has allowed the quadriceps to be extensively and rapidly investigated. Using these techniques, quadriceps force can be related to muscle bulk on CT scan to assess whether muscle weakness in acromegaly occurs in the presence of increased, normal or decreased bulk. The above techniques have been used to make a detailed systemic study of the neuromuscular features of acromegaly.
Patients
Six patients with typical clinical and endocnnological features of acromegaly were studied. Creatinine height index % 66% (2) 118% (1) 116% (2) 81% (1) 138% (20) 113% (2) 90-110% L = Lower limb, A = Arm, B = Both. Numbers in brackets indicate number of estimations, mean quoted. Expressed as % of expected creatinine/height if body weight ideal'" *LLN = Lower limit of normal'3 SAP = reduced sensory action potentials in median, ulna and radial nerve.
MVC of these age matched controls was 120 + 27% were sampled. Changes compati. !e with a myopathy of the lower limit of normal using normal young occurred in only one patient. Evidence of denervasubjects.'3 The lower limit of normal is defined as tion was not detected, even in the patient whose two standard deviations below the predicted normal needle biopsy suggested fibre grouping (patient 2). for body weight. Allowing for age, three of our This patient had mild reduction in sensory action acromegalic patients were weak. potentials in median, ulna and radial nerves but she The EMG and nerve conduction findings are was elderly. The urinary CHI were normal or summarised (table 2). In each patient the abductor increased especially when allowances for age were pollicis brevis, biceps brachialis and vastus medialis made.8 Patient 1 who was the weakest subject in the Needle biopsy of skeletal muscle showed minor, non-specific, but obvious abnormalities on light microscopy in three patients. Large type I fibres, type II fibre atrophy, variation in fibre size and increased internal nuclei were all noted. These findings are common to other endocrine myopathies notably hypothyroidism20 and in keeping with previous work.' 28 '9 Mastaglia8 noted large type I and type II fibres but only five out of his eight biopsies were from the same muscle making comparison difficult. In our patients type I MFA/type II MFA was much higher in the female patients (193%) than in the male patients (1 11%) and was at or above the upper limit of normal in each female. Type I MFA does tend to exceed type II MFA in elderly women,2' but our findings are in excess of the normal variation with age. In our males the type I MFA was at the lower limit of normal or below. Immobility was probably important in patient 1 but patient 6 was active. Patient 1 had also had a hypophysectomy and needed hydrocortisone. The possibility of gonadotrophin lack exists in patient 1 but in patient 6 with hyperprolactinaemia the plasma testosterone was normal.
Type 2 MFA were in the lower normal range or below it in four of our subjects. Histograms show the marked variation in type 2 MFA in patient 6 (fig 2c) 22 23 osteomalacia24 25 and thyrotoxicosis.2326 None of our patients had any evidence of the above disorders, and all were on conventional doses of hydrocortisone replacement. One of our patients had gonadotrophin lack and one had hyperprolactinaemia but so far as we know type 2 fibre atrophy has not been described in association with these disorders.
Ultrastructural changes such as increased subsarcolemmal glycogen accumulation, myofilament loss and increased lipofuscin pigment together with autophagic vacuoles have been well described by Mastaglia, 8 as has the presence of satellite cells. Many of these findings are however non-specific and glycogen accumulation has been described in hypothyroid and corticosteroid myopathies."' l5 20 27 Thus many of the pathological changes seen in acromegaly may also occur in other endocrine disorders. It is possible that GH first stimulates an increase in cell size, possibly by increasing insulin levels. Insulin is known to increase cell size.28 The subsequent type 2 fibre atrophy may be a direct effect of prolonged GH excess or secondary to inactivity either occurring directly or in association with other hormone deficiencies. Speculation that fibre enlargement followed by atrophy may result from GH excess is not new.8 29 Half our patients had had hypophysectomies. Like Mastaglia8 we noted that type 2 fibre atrophy was commoner after hypophysectomy than before it but patient 6 was an exception.
Non-specific factors in acromegaly such as inactivity may be important in influencing muscle mass. They may result from the accompanying osteoarthritis, nerve compression, or chronic airways obstruction which are well known to occur. Certainly patients 1-3 were less active than patients 4-6. Myopathic changes on electromyography and an elevated plasma CK activity were rare in our patients and in those of Lundberg et a!2 but Mastaglia8 found the plasma CK activity helpful. Neuromuscular transmission was delayed in one of our patients and this was also reported by Lundberg et al. 2 Lewis found evidence of a peripheral neuropathy in two patients with pituitary gigantism. '9 In summary quadriceps weakness was confirmed on force measurements and associated with normal muscle bulk on CT scan. Urinary creatinine/height indices (CHI) were also prominent in our acromegalic patients. Needle biopsy from the same proximal muscle frequently showed evidence of "myopathy". Large type I mean fibre area/type II mean fibre area was found in female patients. Type 
